Cat. No. | Product name | CAS No. |
DCC3777 |
Nsc-627757
Novel DNA repair inhibitor |
|
DCC3778 |
Nsc636795
Novel inhibitor of ABCG2 transporter function |
66528-28-7 |
DCC3779 |
Nsc-657186
Novel selective non-zinc-binding MMP-2 inhibitor |
1772-39-0 |
DCC3780 |
Nsc65847
Novel dual inhibitor of viral and Streptococcus pneumoniae neuraminidase |
6949-15-1 |
DCC3781 |
Nsc66098
Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein |
3259-43-6 |
DCC3782 |
Nsc663627
IκBα phosphorylation inhibitor |
51837-75-3 |
DCC3783 |
Nsc-670224
Toxitant of Saccharomyces_cerevisiae>Saccharomyces cerevisiae |
1374648-47-1 |
DCC3784 |
Nsc-672121
Potent CDC25A>Cdc25A inhibitor; Vitamine K3 analogue |
59147-84-1 |
DCC3785 |
Nsc-674205
Potent and selective nociceptin opioid receptor (NOP) agonist |
13130-47-7 |
DCC3786 |
Nsc676914a
Novel NF-κB inhibitor |
|
DCC3787 |
nsc-681152
Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27(Kip1) ubiquitination in vitro |
241128-06-3 |
DCC3788 |
Nsc-689857
Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27Kip1 ubiquitination in vitro |
241127-79-7 |
DCC3789 |
Nsc704342
Novel Inhibitor of HCV NS3/4A Proteinase |
|
DCC3790 |
Nsc705841
Novel selective serotonin reuptake inhibitor (SSRI), exhibiting higher binding affinities in comparison with the paroxetine |
|
DCC3791 |
Nsc724526
Novel Inhibitor of HCV NS3/4A Proteinase |
|
DCC3792 |
Nsc724527
Novel Inhibitor of HCV NS3/4A Proteinase |
|
DCC3793 |
Nsc-73306
Cytotoxic MDR-selective ligand |
79560-74-0 |
DCC3794 |
Nsc-741909
Novel anticancer agent, suppressing the growth of several cell lines derived from lung, colon, breast, ovarian, and kidney cancers |
92407-91-5 |
DCC3795 |
Nsc745885
Novel down-regulator of EZH2, inducing G2/M cell-cycle arrest of cancer cells and degradating p53 via proteasome-dependent and -independent pathways |
4219-52-7 |
DCC3796 |
nsc746364
Telomerase inhibitor, stabilizing G-quadruplex and suppressing cell growth of A549 human lung cancer cells through activation of the ATR/Chk1-dependent pathway |
1190593-30-6 |
DCC3797 |
nsc746365 Maleate
Telomerase inhibitor, anticancer agent |
209176-53-4 |
DCC3798 |
Nsc747854
Novel inhibitor of poly (ADP-ribose) polymerase-1 (PARP-1) |
1329520-12-8 |